Cuproptosis/Apoptosis Co-Activated Immunogenic Cell Death Mediated by a Copper-Based Nanozyme

The highly immunosuppressive tumor microenvironment significantly restricts T-cellmediated antitumor responses, thereby severely limiting the efficacy of immunotherapy.Herein, a mitochondria-targeted nanozyme platform rich in copper ions is rationally designed and engineered for cuproptosis/apoptosis co-activated immunogenic cell death (ICD), and subsequently enhances immunotherapy.In this structure, the disulfiram-copper complex leverages its unique transmembrane transport capability to precisely deliver copper ions into the tumor cells, facilitating the in situ concurrent cuproptosis and apoptosis via mitochondrial dysfunction and enhanced oxidative stress.This combined induction of cuproptosis and apoptosis triggers a pronounced ICD, evidenced by the significant release of DAMPs, such as CRT, HMGB1, and ATP.These signals promote dendritic cell maturation, antigen presentation, and cytotoxic T lymphocyte activation, collectively reprogramming the immunosuppressive tumor microenvironment into an immune activation state.Moreover, the system strategically leverages therapy-induced upregulation of PD-L1 to potentiate immune checkpoint blockade.When integrated with αPD-1 treatment, the rate of tumor suppression attained 96.8%, significantly exceeding the 49.2% effectiveness observed with αPD-1 monotherapy.Therefore, the immunostimulatory strategy that leverages cuproptosis to modulate the tumor microenvironment represents an innovative and promising approach that can effectively enhance the efficacy of immune response in cancer immunotherapy.

Authors

Institutions

Publication Details

Journal
Cyborg and Bionic Systems
Published
2026-11-18
DOI
https://doi.org/10.34133/cbsystems.0772
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cuproptosis/Apoptosis Co-Activated Immunogenic Cell Death Mediated by a Copper-Based Nanozyme

Yunhao Zhang, Chen Dong, Yanqiang Yang, xiaoqun ye et al.
4 links
Cyborg and Bionic Systems
Nanoplatforms for cancer theranostics
article

Cuproptosis/Apoptosis Co-Activated Immunogenic Cell Death Mediated by a Copper-Based Nanozyme

Yunhao Zhang, Chen Dong, Yanqiang Yang, xiaoqun ye, Xinyi Zhang, Xuehua Ma, Yuan Xu, Tianxiang Chen, Aiguo Wu, Changyong Gao
article en

Abstract

The highly immunosuppressive tumor microenvironment significantly restricts T-cellmediated antitumor responses, thereby severely limiting the efficacy of immunotherapy.Herein, a mitochondria-targeted nanozyme platform rich in copper ions is rationally designed and engineered for cuproptosis/apoptosis co-activated immunogenic cell death (ICD), and subsequently enhances immunotherapy.In this structure, the disulfiram-copper complex leverages its unique transmembrane transport capability to precisely deliver copper ions into the tumor cells, facilitating the in situ concurrent cuproptosis and apoptosis via mitochondrial dysfunction and enhanced oxidative stress.This combined induction of cuproptosis and apoptosis triggers a pronounced ICD, evidenced by the significant release of DAMPs, such as CRT, HMGB1, and ATP.These signals promote dendritic cell maturation, antigen presentation, and cytotoxic T lymphocyte activation, collectively reprogramming the immunosuppressive tumor microenvironment into an immune activation state.Moreover, the system strategically leverages therapy-induced upregulation of PD-L1 to potentiate immune checkpoint blockade.When integrated with αPD-1 treatment, the rate of tumor suppression attained 96.8%, significantly exceeding the 49.2% effectiveness observed with αPD-1 monotherapy.Therefore, the immunostimulatory strategy that leverages cuproptosis to modulate the tumor microenvironment represents an innovative and promising approach that can effectively enhance the efficacy of immune response in cancer immunotherapy.

Cyborg and Bionic Systems
Nanchang University (CN), Ningbo University of Finance & Economics (CN), Second Affiliated Hospital of Nanchang University (CN), Second Hospital of Nanchang (CN), Ningbo Institute of Industrial Technology (CN)
National Natural Science Foundation of China, Nanchang University, Natural Science Foundation of Ningbo
Good health and well-being
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon